BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Seminars in Diagnostic Pathology 2017;34:153-9. [DOI: 10.1053/j.semdp.2016.12.011] [Cited by in Crossref: 153] [Cited by in F6Publishing: 269] [Article Influence: 30.6] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Duan Y, Yu X, Zhong J, Bai J, Li NG, Zhu Z, Xu J. Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents. J Enzyme Inhib Med Chem 2022;37:2423-33. [PMID: 36065941 DOI: 10.1080/14756366.2022.2118268] [Reference Citation Analysis]
2 Tian Z, Xu C, Yang P, Lin Z, Wu W, Zhang W, Ding J, Ding R, Zhang X, Dou K. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Front Immunol 2022;13:984728. [DOI: 10.3389/fimmu.2022.984728] [Reference Citation Analysis]
3 Chen S, Liu P, Zhao L, Han P, Liu J, Yang H, Li J. A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma. Front Immunol 2022;13:954653. [DOI: 10.3389/fimmu.2022.954653] [Reference Citation Analysis]
4 Ge S, Xu C, Li Y, Zhang Y, Li N, Wang F, Ding L, Niu J, Shi Z. Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/2469592] [Reference Citation Analysis]
5 Huang J, Li Y, Zheng M, He H, Xu D, Tian D. RNF126 contributes to stem cell-like properties and metastasis in hepatocellular carcinoma through ubiquitination and degradation of LKB1. Hum Cell 2022. [PMID: 36068398 DOI: 10.1007/s13577-022-00782-6] [Reference Citation Analysis]
6 Bhosale PB, Abusaliya A, Kim HH, Ha SE, Park MY, Jeong SH, Vetrivel P, Heo JD, Kim J, Won CK, Kim H, Kim GS. Apigetrin Promotes TNFα-Induced Apoptosis, Necroptosis, G2/M Phase Cell Cycle Arrest, and ROS Generation through Inhibition of NF-κB Pathway in Hep3B Liver Cancer Cells. Cells 2022;11:2734. [DOI: 10.3390/cells11172734] [Reference Citation Analysis]
7 Liu D, Fang JM, Chen XQ. Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis. World J Clin Cases 2022; 10(24): 8547-8555 [DOI: 10.12998/wjcc.v10.i24.8547] [Reference Citation Analysis]
8 Chen W, Zhang F, Xu H, Hou X, Tang D, Dai Y. Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing. Pathol Oncol Res 2022;28:1610199. [DOI: 10.3389/pore.2022.1610199] [Reference Citation Analysis]
9 Mou Y, Ding X. LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p/TM4SF4 axis. Anticancer Drugs 2022. [PMID: 35946523 DOI: 10.1097/CAD.0000000000001326] [Reference Citation Analysis]
10 Hou JP, Shi YB, Fu YF, Li H. I-125 seeds insertion with TACE for advanced HCC: a meta-analysis of randomized controlled trials. Minim Invasive Ther Allied Technol 2022;31:848-55. [PMID: 35107390 DOI: 10.1080/13645706.2022.2033786] [Reference Citation Analysis]
11 Yang SB, Zhang JH, Fu YF, Wang R. TACE with portal vein radioactive seeds for HCC with portal vein tumor thrombus: a meta-analysis. Minim Invasive Ther Allied Technol 2022;31:856-64. [PMID: 35238280 DOI: 10.1080/13645706.2022.2045326] [Reference Citation Analysis]
12 Gao F, Zheng G, Shi Z. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/2959846] [Reference Citation Analysis]
13 Yang L, Zeng L, Hong G, Luo Q, Lai X, Wang F. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/6535009] [Reference Citation Analysis]
14 Li D, Xia C, Chen X, Li Q, Li J, Qian X. Fabrication of novel ruthenium loaded silk fibroin nanomaterials for fingolimod release improved antitumor efficacy in hepatocellular carcinoma. J Biomater Sci Polym Ed 2022;:1-18. [PMID: 35820069 DOI: 10.1080/09205063.2022.2090348] [Reference Citation Analysis]
15 Hu H, Huang W, Zhang H, Li J, Zhang Q, Miao YR, Hu FF, Gan L, Su Z, Yang X, Guo AY. A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma. Cells 2022;11:2116. [PMID: 35805200 DOI: 10.3390/cells11132116] [Reference Citation Analysis]
16 Wang D, Zhang J, Cai L, Dai X. Cold Atmospheric Plasma Conveys Selectivity Against Hepatocellular Carcinoma Cells via Triggering EGFR(Tyr1068)-Mediated Autophagy. Front Oncol 2022;12:895106. [DOI: 10.3389/fonc.2022.895106] [Reference Citation Analysis]
17 Gu J, Liang Y. Clinical Nursing Paths Benefit Patient Outcomes Undergoing Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. Evid Based Complement Alternat Med 2022;2022:4655293. [PMID: 35769161 DOI: 10.1155/2022/4655293] [Reference Citation Analysis]
18 Sun X, Zhong X, Ma W, Feng W, Huang Q, Ma M, Lv M, Hu R, Han Z, Li J, Zhou X. Germacrone induces caspase-3/GSDME activation and enhances ROS production, causing HepG2 pyroptosis. Exp Ther Med 2022;24:456. [PMID: 35747157 DOI: 10.3892/etm.2022.11383] [Reference Citation Analysis]
19 Zhang Y, Lei X, Xu L, Lv X, Xu M, Tang H. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection. BMC Surg 2022;22:233. [PMID: 35715787 DOI: 10.1186/s12893-022-01682-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zhou X, Fu Y, Liu W, Mu Y, Zhang H, Chen J, Liu P. Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges. Front Mol Biosci 2022;9:928321. [DOI: 10.3389/fmolb.2022.928321] [Reference Citation Analysis]
21 Xi B, Luo F, He B, Wang F, Li Z, Lai M, Zheng S. High nuclear ABCG1 expression is a poor predictor for hepatocellular carcinoma patient survival. Hepatobiliary & Pancreatic Diseases International 2022. [DOI: 10.1016/j.hbpd.2022.06.009] [Reference Citation Analysis]
22 Ulu ZO, Bolat ZB, Sahin F. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of sodium perborate on hepatocellular carcinoma cells. Journal of Trace Elements in Medicine and Biology 2022. [DOI: 10.1016/j.jtemb.2022.127011] [Reference Citation Analysis]
23 Gao F, Wang Y, Huang X, Pan T, Guo J. I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02356-0] [Reference Citation Analysis]
24 Liu P, Han B, Zhang Y, Wang X, Ahmad S. Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma. Computational Intelligence and Neuroscience 2022;2022:1-14. [DOI: 10.1155/2022/7102500] [Reference Citation Analysis]
25 Mu X, Zhong Y, Zhang X, Qu C, Chen S. Early Diagnosis Value of DCE-MRI Hemodynamic Parameters in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/9556589] [Reference Citation Analysis]
26 Yi L, He S, Cheng Z, Chen X, Ren X, Bai Y, Santhekadur PK. DNAJA1 Stabilizes EF1A1 to Promote Cell Proliferation and Metastasis of Liver Cancer Mediated by miR-205-5p. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2292481] [Reference Citation Analysis]
27 Greca RD, Cunha-silva M, Mazo DF, Costa LB, Ataíde EC, Boin IF, Sevá-pereira T. Prevalence of Hepatocellular Carcinoma and Its Characteristics in 10 Years of Transplantation in a University Hospital in Brazil. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2022.03.010] [Reference Citation Analysis]
28 Sun M, Liu X, Wei W, Ge N, Luo S, Shen S, Ge R. BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K/AKT Pathway. J Healthc Eng 2022;2022:7686728. [PMID: 35449837 DOI: 10.1155/2022/7686728] [Reference Citation Analysis]
29 Zhang Y, Wang F, Wang Y. LncRNA TSPEAR-AS1 predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma and promotes metastasis via miR-1915-5p. Virus Res 2022;:198788. [PMID: 35477008 DOI: 10.1016/j.virusres.2022.198788] [Reference Citation Analysis]
30 Bae BK, Park HC, Yoo GS, Choi MS, Oh JH, Yu JI. The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 2022;14:2081. [DOI: 10.3390/cancers14092081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Banas B, Kolodziejczyk P, Czerw A, Banas T, Kotwas A, Richter P. A Retrospective, Single-Centre Study on the Learning Curve for Liver Tumor Open Resection in Patients with Hepatocellular Cancers and Intrahepatic Cholagangiocarcinomas. Int J Environ Res Public Health 2022;19:4872. [PMID: 35457739 DOI: 10.3390/ijerph19084872] [Reference Citation Analysis]
32 Hu Q, Li Y, Chen H, Liao H, He Y, Zheng Q. CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma. Front Immunol 2022;13:859331. [DOI: 10.3389/fimmu.2022.859331] [Reference Citation Analysis]
33 Zhao Y, Li M, Miao N, Wei W, Dong Y, Tao C, Chen J, Pei Y, Guo L. Use of miRNA Sequencing to Reveal Hub miRNAs and the Effect of miR-582-3p/SMAD2 in the Progression of Hepatocellular Carcinoma. Front Genet 2022;13:819553. [PMID: 35386287 DOI: 10.3389/fgene.2022.819553] [Reference Citation Analysis]
34 Lu X, Ding Y, Liu H, Sun M, Chen C, Yang Y, Wang H. The Role of Hydrogen Sulfide Regulation of Autophagy in Liver Disorders. Int J Mol Sci 2022;23:4035. [PMID: 35409395 DOI: 10.3390/ijms23074035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Xuan J, Liu Y, Zeng X, Wang H. Sequence Requirements for miR-424-5p Regulating and Function in Cancers. Int J Mol Sci 2022;23:4037. [PMID: 35409396 DOI: 10.3390/ijms23074037] [Reference Citation Analysis]
36 Xia Y, Tang W, Qian X, Li X, Cheng F, Wang K, Zhang F, Zhang C, Li D, Song J, Zhang H, Zhao J, Yao A, Wu X, Wu C, Ji G, Liu X, Zhu F, Qin L, Xiao X, Deng Z, Kong X, Li S, Yu Y, Xi W, Deng W, Qi C, Liu H, Pu L, Wang P, Wang X. Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial. J Immunother Cancer 2022;10:e004656. [DOI: 10.1136/jitc-2022-004656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Yan Q, Sun Y, An R, Liu F, Fang Q, Wang Z, Xu T, Chen L, Du J. Application and progress of the detection technologies in hepatocellular carcinoma. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.04.003] [Reference Citation Analysis]
38 Sun J, Cheng N, Wang F. Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/1688460] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Xia F, Zhu P, Chen XP, Zhang BX, Zhang MY. Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis. J Oncol 2022;2022:7531452. [PMID: 35342424 DOI: 10.1155/2022/7531452] [Reference Citation Analysis]
40 Wei W, Xu R, Ying X, Chen L, Lu X, Tang Q, Xie J, Yu H. Transcriptome Analysis of Solute Carrier-Associated Genes in Hepatocellular Carcinoma: Friend or Foe? Front Genet 2022;13:856393. [DOI: 10.3389/fgene.2022.856393] [Reference Citation Analysis]
41 Zou X, Sun P, Xie H, Fan L, Ding K, Wang J, Li Y. Knockdown of long noncoding RNA HUMT inhibits the proliferation and metastasis by regulating miR-455-5p/LRP4 axis in hepatocellular carcinoma. Bioengineered 2022;13:8051-63. [PMID: 35293286 DOI: 10.1080/21655979.2022.2051841] [Reference Citation Analysis]
42 Sun Z, Xue C, Li J, Zhao H, Du Y, Du N. LINC00244 suppresses cell growth and metastasis in hepatocellular carcinoma by downregulating programmed cell death ligand 1. Bioengineered 2022;13:7635-47. [PMID: 35266439 DOI: 10.1080/21655979.2022.2050073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Foo MA, You M, Chan SL, Sethi G, Bonney GK, Yong WP, Chow EK, Fong ELS, Wang L, Goh BC. Clinical translation of patient-derived tumour organoids- bottlenecks and strategies. Biomark Res 2022;10:10. [PMID: 35272694 DOI: 10.1186/s40364-022-00356-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Shen Q, Xia Y, Yang L, Wang B, Peng J, Tang M. Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/2813521] [Reference Citation Analysis]
45 Takaki K, Nakano M, Fukumori K, Yano Y, Zaizen Y, Niizeki T, Kuwaki K, Fukahori M, Sakaue T, Yoshimura S, Nakazaki M, Torimura T. Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis. J Clin Med 2022;11:1483. [PMID: 35329809 DOI: 10.3390/jcm11061483] [Reference Citation Analysis]
46 Xu L, Zheng Q, Liu W. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma. BMC Cancer 2022;22:229. [PMID: 35236323 DOI: 10.1186/s12885-022-09301-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Sun K, Shi L, Qiu J, Pan Y, Wang X, Wang H. Multi-phase contrast-enhanced magnetic resonance image-based radiomics-combined machine learning reveals microscopic ultra-early hepatocellular carcinoma lesions. Eur J Nucl Med Mol Imaging 2022. [PMID: 35230493 DOI: 10.1007/s00259-022-05742-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yu Q, Chen W, Li Y, He J, Wang Y, Yang S, Zhou J. The novel circular RNA HIPK3 accelerates the proliferation and invasion of hepatocellular carcinoma cells by sponging the micro RNA-124 or micro RNA-506/pyruvate dehydrogenase kinase 2 axis. Bioengineered 2022;13:4717-29. [PMID: 35212603 DOI: 10.1080/21655979.2022.2031398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chen H, Tang C, Tan C, Wu F, Li Z, Ji W, Lu L, Xu C, Shen Z, Huang Y, Ding X. IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3445350] [Reference Citation Analysis]
50 Zhou J, Che J, Xu L, Yang W, Li Y, Zhou W, Zou S. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1. Bioengineered 2022;13:5737-55. [DOI: 10.1080/21655979.2021.2023792] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Chen Y, Zhang J, Liu J, Wang J, Shi C, Lu L, Cheng X, Niu G, Zhang S, Cui D. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. Journal of Immunology Research 2022;2022:1-7. [DOI: 10.1155/2022/1817694] [Reference Citation Analysis]
52 Zheng Y, Zhang W, Xu L, Zhou H, Yuan M, Xu H. Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer. Front Oncol 2021;11:795548. [PMID: 35155196 DOI: 10.3389/fonc.2021.795548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Zhong X, Di Z, Xu Y, Liang Q, Feng K, Zhang Y, Di L, Wang R. Mineral medicine: from traditional drugs to multifunctional delivery systems. Chin Med 2022;17. [DOI: 10.1186/s13020-022-00577-9] [Reference Citation Analysis]
54 Wan Z, Wang X. Role of SLC39A6 in the development and progression of liver cancer. Oncol Lett 2022;23:77. [PMID: 35111246 DOI: 10.3892/ol.2022.13197] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Park D. Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest. Biol Pharm Bull 2022;45:184-93. [PMID: 35110505 DOI: 10.1248/bpb.b21-00697] [Reference Citation Analysis]
56 Dong Y, Liu X, Jiang B, Wei S, Xiang B, Liao R, Wang Q, He X. A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma. Front Oncol 2021;11:780266. [PMID: 35111672 DOI: 10.3389/fonc.2021.780266] [Reference Citation Analysis]
57 Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y. Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma. JHC 2022;Volume 9:41-56. [DOI: 10.2147/jhc.s346047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Ayesha M, Majid A, Zhao D, Greenaway FT, Yan N, Liu Q, Liu S, Sun M. MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A. Journal of Advanced Research 2022;36:147-61. [DOI: 10.1016/j.jare.2021.05.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Ahmad M, Dhasmana A, Harne PS, Zamir A, Hafeez BB. Chemokine Clouding and Liver Cancer Heterogeneity: Does it Impact Clinical Outcomes? Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Shen H, Li H, Zhou J. Circular RNA hsa_circ_0032683 inhibits the progression of hepatocellular carcinoma by sponging microRNA-338-5p. Bioengineered 2022;13:2321-35. [PMID: 35030979 DOI: 10.1080/21655979.2021.2024961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Li H, Wang N, Xu Y, Chang X, Ke J, Yin J. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells. Bioengineered 2022;13:1304-19. [PMID: 34983307 DOI: 10.1080/21655979.2021.2014616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
62 Fang Y, Zhang W. Distribution Characteristics and Species Diversity of Bacteria in Hepatocellular Carcinoma Tissues. j biomater tissue eng 2022;12:97-104. [DOI: 10.1166/jbt.2022.2869] [Reference Citation Analysis]
63 Bektay MY, Güler EM, Gökçe M, Kızıltaş MV. Investigation of the Genotoxic, Cytotoxic, Apoptotic, and Oxidant Effects of Olive Leaf Extracts on Liver Cancer Cell Lines. Turk J Pharm Sci 2021;18:781-9. [PMID: 34979739 DOI: 10.4274/tjps.galenos.2021.03271] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Mao Y, Ding Z, Jiang M, Yuan B, Zhang Y, Zhang X. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27. Biomed J 2021:S2319-4170(21)00181-5. [PMID: 34974169 DOI: 10.1016/j.bj.2021.12.009] [Reference Citation Analysis]
65 Zhu J, Wu Y, Lao S, Shen J, Yu Y, Fang C, Zhang N, Li Y, Zhang R. Targeting TRIM54/Axin1/β-Catenin Axis Prohibits Proliferation and Metastasis in Hepatocellular Carcinoma. Front Oncol 2021;11:759842. [PMID: 34956880 DOI: 10.3389/fonc.2021.759842] [Reference Citation Analysis]
66 Zhu F, Wang BR, Zhu ZF, Wang SQ, Chai CX, Shang D, Li M. Photodynamic therapy: A next alternative treatment strategy for hepatocellular carcinoma? World J Gastrointest Surg 2021; 13(12): 1523-1535 [DOI: 10.4240/wjgs.v13.i12.1523] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 He K, Liu X, Cheng S, Zhou P. Zingiberensis Newsaponin Inhibits the Malignant Progression of Hepatocellular Carcinoma via Suppressing Autophagy Moderated by the AKR1C1-Mediated JAK2/STAT3 Pathway. Evid Based Complement Alternat Med 2021;2021:4055209. [PMID: 34938341 DOI: 10.1155/2021/4055209] [Reference Citation Analysis]
68 Hacioglu C. Capsaicin inhibits cell proliferation by enhancing oxidative stress and apoptosis through SIRT1/NOX4 signaling pathways in HepG2 and HL-7702 cells. J Biochem Mol Toxicol 2021;:e22974. [PMID: 34939720 DOI: 10.1002/jbt.22974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Yan Z, He M, He L, Wei L, Zhang Y. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Front Immunol 2021;12:723271. [PMID: 34925311 DOI: 10.3389/fimmu.2021.723271] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
70 Su D. The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma. Bioengineered 2021;12:11124-35. [PMID: 34923912 DOI: 10.1080/21655979.2021.2001239] [Reference Citation Analysis]
71 Liu R, Jiang Z, Kong W, Zheng S, Dai T, Wang G. A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma. Front Genet 2021;12:730732. [PMID: 34917126 DOI: 10.3389/fgene.2021.730732] [Reference Citation Analysis]
72 Yu MH, Tsai MC, Wang CC, Wu SW, Chang YJ, Wu CH, Wang CJ. Mulberry Leaf Polyphenol Extract and Rutin Induces Autophagy Regulated by p53 in Human Hepatoma HepG2 Cells. Pharmaceuticals (Basel) 2021;14:1310. [PMID: 34959709 DOI: 10.3390/ph14121310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Zhuo W, Li A, Yang W, Duan J, Min J, Wei J. Case Report: Hepatic Artery Infusion Chemotherapy After Stage I ALPPS in a Patient With Huge HCC. Front Surg 2021;8:746618. [PMID: 34901139 DOI: 10.3389/fsurg.2021.746618] [Reference Citation Analysis]
74 Wu J, Ren X, Wang N, Zhou R, Chen M, Cai Y, Lin S, Zhang H, Xie X, Dang C, Zhang S, Zhou Z. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Front Genet 2021;12:779554. [PMID: 34880908 DOI: 10.3389/fgene.2021.779554] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
75 Zhang Q, Wang Y, Zhang J, Zhang W, Gong J, Ma R. TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study. Technol Cancer Res Treat 2021;20:15330338211060180. [PMID: 34855560 DOI: 10.1177/15330338211060180] [Reference Citation Analysis]
76 Chen X, Song J, Wang X, Sun D, Liu Y, Jiang Y. LncRNA LINC00460: Function and mechanism in human cancer. Thorac Cancer 2022;13:3-14. [PMID: 34821482 DOI: 10.1111/1759-7714.14238] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Zheng L, Li H, Huang J, Shin J, Luo S, Guo C, Zhao Y, Li F. Serum midkine levels for the diagnosis and assessment of response to interventional therapy in patients with hepatocellular carcinoma. J Interv Med 2021;4:39-45. [PMID: 34805946 DOI: 10.1016/j.jimed.2020.10.009] [Reference Citation Analysis]
78 Sun W, Hu C, Wang T, Wang J, Zhang J, Gao F, Ou Q, Tian H, Jin C, Xu J, Zhang J, Xu GT, Lu L. Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Front Oncol 2021;11:744331. [PMID: 34796110 DOI: 10.3389/fonc.2021.744331] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
79 Bi J, Guo Y, Li Q, Liu L, Bao S, Xu P. Role of long intergenic non-protein coding RNA 01857 in hepatocellular carcinoma malignancy via the regulation of the microRNA-197-3p/anterior GRadient 2 axis. PLoS One 2021;16:e0258312. [PMID: 34793477 DOI: 10.1371/journal.pone.0258312] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
80 Huang C, Yu W, Wang Q, Huang T, Ding Y. CircANTXR1 Contributes to the Malignant Progression of Hepatocellular Carcinoma by Promoting Proliferation and Metastasis. J Hepatocell Carcinoma 2021;8:1339-53. [PMID: 34786378 DOI: 10.2147/JHC.S317256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Ding Q, Lin D, Zhou Y, Li F, Lai J, Duan J, Chen J, Jiang C. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma. Oncol Lett 2021;22:857. [PMID: 34777591 DOI: 10.3892/ol.2021.13118] [Reference Citation Analysis]
82 Hong J, Cao L, Xie H, Liu Y, Yu J, Zheng S. Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis. Hepatobiliary Surg Nutr 2021;10:623-30. [PMID: 34760966 DOI: 10.21037/hbsn.2020.03.15] [Reference Citation Analysis]
83 Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P. Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus 2021;13:e19274. [PMID: 34754704 DOI: 10.7759/cureus.19274] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
84 Cheng J, Li Y, Wang X, Dong Z, Chen Y, Zhang R, Huang J, Jin X, Yao J, Ge A, Song L, Lu Y, Zeng Z. Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels. J Hepatocell Carcinoma 2021;8:1281-95. [PMID: 34737983 DOI: 10.2147/JHC.S326356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Li X, Xu J, Gu X, Chen L, Wu Q, Li H, Bai H, Yang J, Qian J. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma. Front Immunol 2021;12:740790. [PMID: 34733279 DOI: 10.3389/fimmu.2021.740790] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
86 Lu HL, Xuan FF, Luo YC, Qin X. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt. Abdom Radiol (NY) 2021;46:5417-27. [PMID: 34302511 DOI: 10.1007/s00261-021-03214-5] [Reference Citation Analysis]
87 Ditty MJ, Ezhilarasan D. β-sitosterol induces reactive oxygen species-mediated apoptosis in human hepatocellular carcinoma cell line. Avicenna J Phytomed 2021;11:541-50. [PMID: 34804892 DOI: 10.22038/AJP.2021.17746] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Sun Z, Zhao L, Wang S, Wang H. Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis. Ann Hepatol 2021;:100571. [PMID: 34718169 DOI: 10.1016/j.aohep.2021.100571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Shi F, Cao S, Zhu Y, Yu Q, Guo W, Zhang S. High expression of DHX9 promotes the growth and metastasis of hepatocellular carcinoma. J Clin Lab Anal 2021;:e24052. [PMID: 34676915 DOI: 10.1002/jcla.24052] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
90 Zaizen Y, Nakano M, Fukumori K, Yano Y, Takaki K, Niizeki T, Kuwaki K, Fukahori M, Sakaue T, Yoshimura S, Nakazaki M, Kuromatsu R, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T. Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Cancers (Basel) 2021;13:5282. [PMID: 34771452 DOI: 10.3390/cancers13215282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Chen X, She P, Wang C, Shi L, Zhang T, Wang Y, Li H, Qian L, Li M. Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2. J Clin Lab Anal 2021;:e23991. [PMID: 34664737 DOI: 10.1002/jcla.23991] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Tian B, Zhou L, Wang J, Yang P. miR-660-5p-loaded M2 macrophages-derived exosomes augment hepatocellular carcinoma development through regulating KLF3. Int Immunopharmacol 2021;101:108157. [PMID: 34673296 DOI: 10.1016/j.intimp.2021.108157] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
93 Zhang Y, Lu C, Cui H. Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p. Bioengineered 2021;12:7446-58. [PMID: 34652260 DOI: 10.1080/21655979.2021.1975969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
94 Fang J, Zhu H, Xu P, Jiang R. Zingerone suppresses proliferation, invasion, and migration of hepatocellular carcinoma cells by the inhibition of MTDH-mediated PI3K/Akt pathway. J Recept Signal Transduct Res 2021;:1-9. [PMID: 34645355 DOI: 10.1080/10799893.2021.1988970] [Reference Citation Analysis]
95 Cui M, Liu D, Xiong W, Wang Y, Mi J. ERRFI1 induces apoptosis of hepatocellular carcinoma cells in response to tryptophan deficiency. Cell Death Discov 2021;7:274. [PMID: 34608122 DOI: 10.1038/s41420-021-00666-y] [Reference Citation Analysis]
96 Chen C, Su N, Li G, Shen Y, Duan X. Long non-coding RNA TMCC1-AS1 predicts poor prognosis and accelerates epithelial-mesenchymal transition in liver cancer. Oncol Lett 2021;22:773. [PMID: 34589152 DOI: 10.3892/ol.2021.13034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Dong X, Tong Y. Curcumin Nanoparticles Inhibit Liver Cancer by Inhibiting Angiogenesis. sci adv mater 2021;13:1878-84. [DOI: 10.1166/sam.2021.4118] [Reference Citation Analysis]
98 Lin Y, Zheng ZH, Wang JX, Zhao Z, Peng TY. Tumor Cell-Derived Exosomal Circ-0072088 Suppresses Migration and Invasion of Hepatic Carcinoma Cells Through Regulating MMP-16. Front Cell Dev Biol 2021;9:726323. [PMID: 34568335 DOI: 10.3389/fcell.2021.726323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
99 Tang J, Huang Z, Xu J, Lv Q, Wang P. Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history. Clin Res Hepatol Gastroenterol 2021;:101814. [PMID: 34597848 DOI: 10.1016/j.clinre.2021.101814] [Reference Citation Analysis]
100 Wu D, Zhang R, Zhan L. Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile. Clin Res Hepatol Gastroenterol 2021;46:101812. [PMID: 34597849 DOI: 10.1016/j.clinre.2021.101812] [Reference Citation Analysis]
101 Wang H, Zhang Q, Cui W, Li W, Zhang J. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway. Cell Cycle 2021;20:2125-36. [PMID: 34570663 DOI: 10.1080/15384101.2021.1962633] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Xie A, Xia F, Pei J, Sun X, Song Z. Advanced hepatocellular carcinoma treated by radiofrequency ablation combined with oncolytic virus and anti-PD-1 antibody therapy: a case report and literature review. J Int Med Res 2021;49:3000605211044596. [PMID: 34559020 DOI: 10.1177/03000605211044596] [Reference Citation Analysis]
103 Liu X, Dong S, Dong M, Li Y, Sun Z, Zhang X, Wang Y, Teng L, Wang D. Transferrin-conjugated liposomes loaded with carnosic acid inhibit liver cancer growth by inducing mitochondria-mediated apoptosis. Int J Pharm 2021;607:121034. [PMID: 34425193 DOI: 10.1016/j.ijpharm.2021.121034] [Reference Citation Analysis]
104 Huang Z, Xia H, Liu S, Zhao X, He R, Wang Z, Shi W, Chen W, Kang P, Su Z, Cui Y, Yam JWP, Xu Y. The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma. Front Oncol 2021;11:714665. [PMID: 34540684 DOI: 10.3389/fonc.2021.714665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Zhang H, Zhao X, Yu W. Factors Associated with Recurrence of Hepatocellular Carcinoma in 197 Patients Following Transarterial Chemoembolization: A Retrospective Study from a Single Center. Med Sci Monit 2021;27:e929879. [PMID: 34531359 DOI: 10.12659/MSM.929879] [Reference Citation Analysis]
106 Meng M, Wu YC. Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma. J Immunol Res 2021;2021:1782728. [PMID: 34527749 DOI: 10.1155/2021/1782728] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
107 Chen Z, Zou Y, Zhang Y, Chen Z, Wu F, Shi N, Jin H. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma. J Clin Lab Anal 2021;35:e24005. [PMID: 34523732 DOI: 10.1002/jcla.24005] [Reference Citation Analysis]
108 Li H, Wang M, Chen P, Li F, Kuang D, Han X, Ren J, Duan X. Occurrence, Related Factors and Prognostic Value of Vascular Lake in Hepatocellular Carcinoma Patients Treated with Drug-Eluting Bead Transarterial Chemoembolization. Onco Targets Ther 2021;14:4659-70. [PMID: 34511935 DOI: 10.2147/OTT.S297523] [Reference Citation Analysis]
109 Antoine AR, Joyce S, Joanna S, Christine K, Khoury Salem E, Philippe S. Gastrointestinal cancer characteristics in Lebanon. Arab J Gastroenterol 2021:S1687-1979(21)00065-4. [PMID: 34509388 DOI: 10.1016/j.ajg.2021.08.001] [Reference Citation Analysis]
110 Chao X, Zhang W, Wu J, Feng X, Shi H, Zhao L, Shen H, Jiang C. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma. Biomed Res Int 2021;2021:1971048. [PMID: 34485511 DOI: 10.1155/2021/1971048] [Reference Citation Analysis]
111 Ye Y, Yu F, Li Z, Xie Y, Yu X. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA. Bioengineered 2021;12:6144-54. [PMID: 34486474 DOI: 10.1080/21655979.2021.1972785] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
112 Liu R, Kong W, Jiang Z, Zheng S, Yuan X, Ye L. ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma. J Oncol 2021;2021:1379706. [PMID: 34484330 DOI: 10.1155/2021/1379706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Cai Y, Wu D, Zhan L. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis. Clin Res Hepatol Gastroenterol 2021;:101796. [PMID: 34500119 DOI: 10.1016/j.clinre.2021.101796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
114 Zhang K, Liu H, Yu M, Zhao H, Yang N, Bi X, Sun L, Lin R, Lü G. Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma. Front Oncol 2021;11:650173. [PMID: 34458133 DOI: 10.3389/fonc.2021.650173] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Huang X, Qiu Z, Li L, Chen B, Huang P. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Aging (Albany NY) 2021;13:20698-715. [PMID: 34461607 DOI: 10.18632/aging.203456] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
116 Shyu S, Ali SZ. Significance of hepatocyte atypia in liver fine needle aspiration. Diagn Cytopathol 2021. [PMID: 34459153 DOI: 10.1002/dc.24851] [Reference Citation Analysis]
117 Bao H, Muge Q. Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism. Pharm Biol 2021;59:1126-32. [PMID: 34410900 DOI: 10.1080/13880209.2021.1961825] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
118 Zhai CT, Tian YC, Tang ZX, Shao LJ. RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy-related-1 in vitro and in vivo. Kaohsiung J Med Sci 2021. [PMID: 34370374 DOI: 10.1002/kjm2.12430] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Wang L, Wang X, Wang X. The effectiveness of enteral nutrition for patients with primary liver cancer: A randomized controlled study protocol. Medicine (Baltimore) 2021;100:e23973. [PMID: 33545982 DOI: 10.1097/MD.0000000000023973] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Li F, Sun X, Liu Q, Liu X, Zhang J. Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6. Gastroenterol Res Pract 2021;2021:6832518. [PMID: 34381502 DOI: 10.1155/2021/6832518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Wu Q, Liu TY, Hu BC, Li X, Wu YT, Sun XT, Jiang XW, Wang S, Qin XC, Ding HW, Zhao QC. CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways. Front Oncol 2021;11:717626. [PMID: 34395292 DOI: 10.3389/fonc.2021.717626] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
122 Xu L, Zheng Q. A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules. J Oncol 2021;2021:5033416. [PMID: 34367283 DOI: 10.1155/2021/5033416] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Sun Q, Zhang X, Tan Z, Gu H, Ding S, Ji Y. Bone marrow mesenchymal stem cells-secreted exosomal microRNA-205-5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3. Pathol Res Pract 2021;225:153549. [PMID: 34329837 DOI: 10.1016/j.prp.2021.153549] [Reference Citation Analysis]
124 Dong Y, Wang Q, Sun J, Liu H, Wang H. Long non-coding RNA TPTEP1 exerts inhibitory effects on hepatocellular carcinoma by impairing microRNA-454-3p-mediated DLG5 downregulation. Dig Liver Dis 2021:S1590-8658(21)00199-7. [PMID: 34238665 DOI: 10.1016/j.dld.2021.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Hou Y, Zhang G. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis. Diagn Pathol 2021;16:57. [PMID: 34218795 DOI: 10.1186/s13000-021-01118-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
126 Liu Y, Zou H, Xie Q, Zou L, Kong R, Mao B. Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression. Biomed Eng Online 2021;20:67. [PMID: 34217312 DOI: 10.1186/s12938-021-00903-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Chen MY, Yadav VK, Chu YC, Ong JR, Huang TY, Lee KF, Lee KH, Yeh CT, Lee WH. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers (Basel) 2021;13:3227. [PMID: 34203465 DOI: 10.3390/cancers13133227] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
128 Wang Y, Zhang B, Huang Y, Yao W, Tao F, Chen Y. Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway. Molecules 2021;26:3915. [PMID: 34206871 DOI: 10.3390/molecules26133915] [Reference Citation Analysis]
129 Lin X, Xiang X, Feng B, Zhou H, Wang T, Chu X, Wang R. Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects. Front Oncol 2021;11:670838. [PMID: 34249710 DOI: 10.3389/fonc.2021.670838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Lu H, Zheng C, Liang B, Xiong B. Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis. BMC Gastroenterol 2021;21:256. [PMID: 34116638 DOI: 10.1186/s12876-021-01839-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Wang H, Wang H, Cui W, Zhang Q, Li J, Zhang Q. Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma. Diagn Pathol 2021;16:51. [PMID: 34116691 DOI: 10.1186/s13000-021-01111-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Xu R, Lin L, Zhang B, Wang J, Zhao F, Liu X, Li Y, Li Y. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5. BMC Cancer 2021;21:687. [PMID: 34112092 DOI: 10.1186/s12885-021-08390-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
133 Song Y, Jin X, Liu Y, Wang S, Bian F, Zhao Q, Shi H, Gao Z. Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis. Anticancer Drugs 2021;32:812-21. [PMID: 34102651 DOI: 10.1097/CAD.0000000000001070] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
134 He D, Liao S, Cai L, Huang W, Xie X, You M. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma. BMC Cancer 2021;21:599. [PMID: 34034705 DOI: 10.1186/s12885-021-08314-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Guo J, Wang S, Han Y, Jia Z, Wang R. Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma. Oncol Lett 2021;22:554. [PMID: 34084221 DOI: 10.3892/ol.2021.12815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
136 Li L, Xie R, Lu G. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Biosci Rep 2021;41:BSR20210760. [PMID: 34027555 DOI: 10.1042/BSR20210760] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
137 Gao C, Wen Y, Jiang F, Gu X, Zhu X. Circular RNA circ_0008274 upregulates granulin to promote the progression of hepatocellular carcinoma via sponging microRNA -140-3p. Bioengineered 2021;12:1890-901. [PMID: 34002672 DOI: 10.1080/21655979.2021.1926195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
138 He Y, Tao W, Shang C, Qi C, Ji D, Lu W, Chen G. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway. Int J Exp Pathol 2021;102:157-62. [PMID: 33993564 DOI: 10.1111/iep.12396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Chen J, Chen C, Lin Y, Su Y, Yu X, Jiang Y, Chen Z, Ke S, Lin S, Chen L, Zhang Z, Zhang T. Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion. FEBS Open Bio 2021;11:1771-84. [PMID: 33989451 DOI: 10.1002/2211-5463.13173] [Reference Citation Analysis]
140 Wang SY, Yin L, Wang C, Ma MP. Atypical magnetic resonance imaging features and differential diagnosis of hepatocellular carcinoma. J Int Med Res 2020;48:300060520943415. [PMID: 33081554 DOI: 10.1177/0300060520943415] [Reference Citation Analysis]
141 Lu H, Zheng C, Liang B, Xiong B. Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis. BMC Cancer 2021;21:513. [PMID: 33962555 DOI: 10.1186/s12885-021-08253-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
142 Zhang Y, Zhang H, Wu S. LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940. J Hepatocell Carcinoma 2021;8:333-48. [PMID: 33977095 DOI: 10.2147/JHC.S306484] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
143 Chen Y, Song S, Zhang L, Zhang Y. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis. Clin Transl Oncol 2021. [PMID: 33934291 DOI: 10.1007/s12094-021-02627-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Dai M, Chen N, Li J, Tan L, Li X, Wen J, Lei L, Guo D. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms. Phytomedicine 2021;87:153580. [PMID: 34029939 DOI: 10.1016/j.phymed.2021.153580] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
145 Feng Y, Hao F. Hansenia weberbaueriana (Fedde ex H.Wolff) Pimenov & Kljuykov Extract Suppresses Proliferation of HepG2 Cells via the PTEN-PI3K-AKT Pathway Uncovered by Integrating Network Pharmacology and Iin Vitro Experiments. Front Pharmacol 2021;12:620897. [PMID: 33967754 DOI: 10.3389/fphar.2021.620897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Peña-Asensio J, Calvo H, Torralba M, Miquel J, Sanz-de-Villalobos E, Larrubia JR. Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:1922. [PMID: 33923463 DOI: 10.3390/cancers13081922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
147 Guo Y, Chai B, Jia J, Yang M, Li Y, Zhang R, Wang S, Xu J. KLF7/VPS35 axis contributes to hepatocellular carcinoma progression through CCDC85C-activated β-catenin pathway. Cell Biosci 2021;11:73. [PMID: 33858520 DOI: 10.1186/s13578-021-00585-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
148 Ma X, Ding Y, Zeng L. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma. BMC Cancer 2021;21:418. [PMID: 33858382 DOI: 10.1186/s12885-021-08161-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
149 Dahdaleh FS, Naffouje SA, Sherman SK, Kamarajah SK, Salti GI. Tissue Diagnosis Is Associated With Worse Survival in Hepatocellular Carcinoma: A National Cancer Database Analysis. Am Surg 2021;:3134821991983. [PMID: 33830824 DOI: 10.1177/0003134821991983] [Reference Citation Analysis]
150 Shi Y, Zhang L, Bao Y, Wu P, Zhang X. Association of TNIP1 polymorphisms with hepatocellular carcinoma in a Northwest Chinese Han population. Medicine (Baltimore) 2021;100:e24843. [PMID: 33761643 DOI: 10.1097/MD.0000000000024843] [Reference Citation Analysis]
151 Zhang X, Zhang X, Li X, Bao H, Li G, Li N, Li H, Dou J. Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis. Med Sci Monit 2021;27:e926760. [PMID: 33788826 DOI: 10.12659/MSM.926760] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
152 Ren Q, Xiao X, Leng X, Zhang Q, Zhou X, Ren Z, Xiao H. MicroRNA-361-5p induces hepatocellular carcinoma cell apoptosis and enhances drug sensitivity by targeting MAP3K9. Exp Ther Med 2021;21:574. [PMID: 33850546 DOI: 10.3892/etm.2021.10006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Lim LJ, Ling LH, Neo YP, Chung AYF, Goh BKP, Chow PKH, Chan CY, Cheow PC, Lee SY, Lim TKH, Chong SS, Ooi LLPJ, Lee CG. Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients. J Cancer 2021;12:3098-113. [PMID: 33976720 DOI: 10.7150/jca.56340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Zhang J, Wang X, Li G, He J, Lu Z, Yang Y, Jiang Y, Jiang L, Li F, Liu J. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC. Biomed Res Int 2021;2021:6648078. [PMID: 33824874 DOI: 10.1155/2021/6648078] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
155 Liu J, Chen Z, Li W. Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients. J Oncol 2021;2021:6676537. [PMID: 33790969 DOI: 10.1155/2021/6676537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Ding H, Hu H, Tian F, Liang H. A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma. Biosci Rep 2021;41:BSR20204219. [PMID: 33656546 DOI: 10.1042/BSR20204219] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Xu H, Wei W, Y M, Dong C. Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis. Biosci Rep 2020;40:BSR20194019. [PMID: 31872855 DOI: 10.1042/BSR20194019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
158 Tu K, Li J, Mo H, Xian Y, Xu Q, Xiao X. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. Int J Med Sci 2021;18:2030-41. [PMID: 33850474 DOI: 10.7150/ijms.56289] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
159 Wang H, Wang R, Huang D, Li S, Gao B, Kang Z, Tang B, Xie J, Yan F, Liang R, Li H, Yan J. Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway. Front Pharmacol 2021;12:592071. [PMID: 33716735 DOI: 10.3389/fphar.2021.592071] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
160 Chen J, Yang J, Xu Q, Wang Z, Wu J, Pan L, Huang K, Wang C. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20202063. [PMID: 33605411 DOI: 10.1042/BSR20202063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
161 Wang M, Tao H, Huang P. Clinical significance of LARGE1 in progression of liver cancer and the underlying mechanism. Gene 2021;779:145493. [PMID: 33588034 DOI: 10.1016/j.gene.2021.145493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Lou W, Chen J, Ding B, Fan W. XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma. Genomics 2021;113:933-45. [PMID: 33588071 DOI: 10.1016/j.ygeno.2021.02.003] [Reference Citation Analysis]
163 Su Q, Wang H. Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511. Clin Res Hepatol Gastroenterol 2021;45:101648. [PMID: 33588099 DOI: 10.1016/j.clinre.2021.101648] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
164 Wang T, Li P, Wan T, Tu B, Li J, Huang F. TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy. J Drug Target 2021;29:783-91. [PMID: 33480288 DOI: 10.1080/1061186X.2021.1879088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
165 Tian J, Zhao Y, Li L, Cui Y, Wu Y. MicroRNA-936 Targets JAG1 and Inhibits the Proliferation of Hepatocellular Carcinoma Cells. Technol Cancer Res Treat 2021;20:1533033820985785. [PMID: 33550933 DOI: 10.1177/1533033820985785] [Reference Citation Analysis]
166 Kovac JD, Ivanovic A, Milovanovic T, Micev M, Alessandrino F, Gore RM. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiol Oncol 2021;55:130-43. [PMID: 33544992 DOI: 10.2478/raon-2021-0004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
167 Liu L, Shui Y, Yu Q, Guo Y, Zhang L, Zhou X, Yu R, Lou J, Wei S, Wei Q. Narrow-Margin Hepatectomy Resulted in Higher Recurrence and Lower Overall Survival for R0 Resection Hepatocellular Carcinoma. Front Oncol 2020;10:610636. [PMID: 33552983 DOI: 10.3389/fonc.2020.610636] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
168 Fei ZY, Wang WS, Li SF, Zi JJ, Yang L, Liu T, Ao S, Liu QQ, Cui QH, Yu M, Xiong W. High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma. J Gastrointest Oncol 2020;11:1291-304. [PMID: 33457002 DOI: 10.21037/jgo-20-120] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Le J, Fu Y, Han Q, Ma Y, Ji H, Wei X, Chen Y, Sun Y, Gao Y, Wu H. Transcriptome Analysis of the Inhibitory Effect of Sennoside A on the Metastasis of Hepatocellular Carcinoma Cells. Front Pharmacol 2020;11:566099. [PMID: 33708105 DOI: 10.3389/fphar.2020.566099] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
170 Wang Q, Tang M, Zhang S. Comparison of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: a meta-analysis. ANZ J Surg 2021;91:E432-8. [PMID: 33404115 DOI: 10.1111/ans.16560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Min J, Jin D, Zhang F, Kang Y, Qi Y, Du P. DLG1-AS1 is activated by MYC and drives the proliferation and migration of hepatocellular carcinoma cells through miR-497-5p/SSRP1 axis. Cancer Cell Int 2021;21:16. [PMID: 33407499 DOI: 10.1186/s12935-020-01667-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T; Kurume Liver Cancer Study Group of Japan. Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma. ESMO Open 2021;6:100020. [PMID: 33399083 DOI: 10.1016/j.esmoop.2020.100020] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
173 Zhang XW, Li QH, Xu ZD, Dou JJ. STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis. Cell Death Dis 2021;12:31. [PMID: 33414427 DOI: 10.1038/s41419-020-03300-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
174 Chen W, Wei T, Chen Y, Yang L, Wu X. Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway. Onco Targets Ther 2020;13:12787-96. [PMID: 33363384 DOI: 10.2147/OTT.S260793] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
175 Liu Y, Zhang X, Zhang J, Tan J, Li J, Song Z. Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma. Front Cell Dev Biol 2020;8:596679. [PMID: 33425905 DOI: 10.3389/fcell.2020.596679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 47] [Article Influence: 3.0] [Reference Citation Analysis]
176 Liang C, Dong Z, Cai X, Shen J, Xu Y, Zhang M, Li H, Yu W, Chen W. Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma. Cell Death Dis 2020;11:1017. [PMID: 33250518 DOI: 10.1038/s41419-020-03233-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
177 Liu P, Tang Q, Chen M, Chen W, Lu Y, Liu Z, He Z. Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma. Front Oncol 2020;10:589908. [PMID: 33330071 DOI: 10.3389/fonc.2020.589908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
178 Zhang Y, Wang H, Li C, Gao L, Zheng Y, Chang W, Lu C, Zhao X. CircSMYD4 regulates proliferation, migration and apoptosis of hepatocellular carcinoma cells by sponging miR-584-5p. Cancer Cell Int 2020;20:556. [PMID: 33292243 DOI: 10.1186/s12935-020-01648-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
179 Lorenc T, Chrzanowski J, Olejarz W. Current Perspectives on Clinical Use of Exosomes as a Personalized Contrast Media and Theranostics. Cancers (Basel) 2020;12:E3386. [PMID: 33207614 DOI: 10.3390/cancers12113386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
180 Sheng QJ, Tian WY, Dou XG, Zhang C, Li YW, Han C, Fan YX, Lai PP, Ding Y. Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(11): 1255-1271 [PMID: 33250959 DOI: 10.4251/wjgo.v12.i11.1255] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
181 Wang X, Tan Y, Zhang Y, Xu Z, Xu B, Lei H, Ding C, Cheng S, Wang X, Wei P, Wang Z, Mao Q, Ai C, Hua Q. The novel glycyrrhetinic acid–tetramethylpyrazine conjugate TOGA induces anti-hepatocarcinogenesis by inhibiting the effects of tumor-associated macrophages on tumor cells. Pharmacological Research 2020;161:105233. [DOI: 10.1016/j.phrs.2020.105233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
182 Liu Z, Li Z, Xu B, Yao H, Qi S, Tai J. Long Noncoding RNA PRR34-AS1 Aggravates the Progression of Hepatocellular Carcinoma by Adsorbing microRNA-498 and Thereby Upregulating FOXO3. Cancer Manag Res 2020;12:10749-62. [PMID: 33154667 DOI: 10.2147/CMAR.S263619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
183 Xu D, Wang Y, Wu J, Zhang Z, Chen J, Xie M, Tang R, Cheng C, Chen L, Lin S, Luo X, Zheng J. MTIF2 impairs 5 fluorouracil-mediated immunogenic cell death in hepatocellular carcinoma in vivo: Molecular mechanisms and therapeutic significance. Pharmacol Res 2021;163:105265. [PMID: 33129983 DOI: 10.1016/j.phrs.2020.105265] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
184 Wang B, Yang S, Zhao W. Long Non-Coding RNA NRAD1 and LINC00152 are Highly Expressed and Associated with Prognosis in Patients with Hepatocellular Carcinoma. Onco Targets Ther 2020;13:10409-16. [PMID: 33116620 DOI: 10.2147/OTT.S251231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
185 Cui Z, Li Y, Gao Y, Kong L, Lin Y, Chen Y. Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction. Aging (Albany NY) 2020;12:19455-67. [PMID: 33035196 DOI: 10.18632/aging.103879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
186 Li J, Zhou J, Kai S, Wang C, Wang D, Jiang J. Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:1371632. [PMID: 33083449 DOI: 10.1155/2020/1371632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Vale N, Duarte D, Silva S, Correia AS, Costa B, Gouveia MJ, Ferreira A. Cell-penetrating peptides in oncologic pharmacotherapy: A review. Pharmacol Res 2020;162:105231. [PMID: 33027717 DOI: 10.1016/j.phrs.2020.105231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
188 Li J, Zhou J, Kai S, Wang C, Wang D, Jiang J. Functional and Clinical Characterization of Tumor-Infiltrating T Cell Subpopulations in Hepatocellular Carcinoma. Front Genet 2020;11:586415. [PMID: 33133170 DOI: 10.3389/fgene.2020.586415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Ma D, Wang J, Liu L, Chen M, Wang Z. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study. BMC Cancer 2020;20:936. [PMID: 32993568 DOI: 10.1186/s12885-020-07447-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
190 Cao Y, Zhang F, Wang H, Bi C, Cui J, Liu F, Pan H. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis. Mol Cell Biochem 2021;476:279-92. [PMID: 32965597 DOI: 10.1007/s11010-020-03904-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
191 Li Y, Xu X, Weng S, Yan C, Chen J, Ye R. CT Image-Based Texture Analysis to Predict Microvascular Invasion in Primary Hepatocellular Carcinoma. J Digit Imaging 2020;33:1365-75. [PMID: 32968880 DOI: 10.1007/s10278-020-00386-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
192 Chi X, Jiang Y, Chen Y, Lv L, Chen J, Yang F, Zhang X, Pan F, Cai Q. microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway. Biomark Med 2020;14:981-96. [PMID: 32940078 DOI: 10.2217/bmm-2019-0511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Fernandes GDS, Campos D, Ballalai A, Palhares R, da Silva MRA, Palhares DMF, Neto BF, Barros FMDR, Gil RA, Chagas A, Carrilho FJ. Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data. J Gastrointest Cancer 2021;52:952-8. [PMID: 32918274 DOI: 10.1007/s12029-020-00508-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
194 Ding H, Liu J, Wang C, Su Y. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA. Cancer Cell Int 2020;20:425. [PMID: 32884448 DOI: 10.1186/s12935-020-01520-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
195 Li J, Xue F, Xu X, Wang Q, Zhang X. Dynamic contrast-enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features. Exp Ther Med 2020;20:3643-52. [PMID: 32855716 DOI: 10.3892/etm.2020.9115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
196 Jiang Z, Wang S, Hou J, Chi J, Wang S, Shao K, Liu W, Sun R, Han B. Effects of carboxymethyl chitosan oligosaccharide on regulating immunologic function and inhibiting tumor growth. Carbohydr Polym 2020;250:116994. [PMID: 33049904 DOI: 10.1016/j.carbpol.2020.116994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
197 Nandhini JT, Ezhilarasan D, Rajeshkumar S. An ecofriendly synthesized gold nanoparticles induces cytotoxicity via apoptosis in HepG2 cells. Environmental Toxicology 2021;36:24-32. [DOI: 10.1002/tox.23007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
198 Chen Q, Li F, Gao Y, Xu G, Liang L, Xu J. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma. Front Oncol 2020;10:1210. [PMID: 32903581 DOI: 10.3389/fonc.2020.01210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
199 Jin S, Tan S, Peng W, Jiang Y, Luo C. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis. World J Surg Oncol 2020;18:199. [PMID: 32787883 DOI: 10.1186/s12957-020-01966-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
200 Parama D, Boruah M, Yachna K, Rana V, Banik K, Harsha C, Thakur KK, Dutta U, Arya A, Mao X, Ahn KS, Kunnumakkara AB. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases. Life Sci 2020;260:118182. [PMID: 32781063 DOI: 10.1016/j.lfs.2020.118182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
201 He S, Guo Z, Kang Q, Wang X, Han X. Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis. Cancer Cell Int 2020;20:360. [PMID: 32774154 DOI: 10.1186/s12935-020-01447-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
202 Falkson SR, Bhambhvani HP, Hayden Gephart M. Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience. World Neurosurgery 2020;140:e27-32. [DOI: 10.1016/j.wneu.2020.03.189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
203 Zhang Y, Jiang X, Li X, Găman MA, Kord-Varkaneh H, Rahmani J, Salehi-Sahlabadi A, Day AS, Xu Y. Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies. Nutr Cancer 2021;73:1-9. [PMID: 32705896 DOI: 10.1080/01635581.2020.1797127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
204 Liu W, Yin C, Liu Y. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm 2020. [PMID: 32673066 DOI: 10.1089/cbr.2019.3472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
205 Grazzini G, Cozzi D, Flammia F, Grassi R, Agostini A, Belfiore MP, Borgheresi A, Mazzei MA, Floridi C, Carrafiello G, Giovagnoni A, Pradella S, Miele V. Hepatic tumors: pitfall in diagnostic imaging. Acta Biomed 2020;91:9-17. [PMID: 32945274 DOI: 10.23750/abm.v91i8-S.9969] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Ye L, Zhu L, Wang J, Li F. Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo. Open Med (Wars) 2020;15:663-71. [PMID: 33336024 DOI: 10.1515/med-2020-0137] [Reference Citation Analysis]
207 Jiang Z, Zhang C, Liu X, Ma X, Bian X, Xiao X, Gao R, Sun Y, Wu W, Zhao P. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4. Int J Oncol 2020;57:780-90. [PMID: 32705164 DOI: 10.3892/ijo.2020.5097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
208 Fleming BD, Ho M. Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update. Biomolecules 2020;10:E934. [PMID: 32575752 DOI: 10.3390/biom10060934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
209 Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T; Kurume Liver Cancer Study Group of Japan. Primary Treatment with Molecular-Targeted Agents for Hepatocellular Carcinoma: A Propensity Score-matching Analysis. Hepatol Commun 2020;4:1218-28. [PMID: 32766480 DOI: 10.1002/hep4.1535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
210 Vishnevsky VA, Ayvazyan KA, Ikramov RZ, Ionkin DA, Zhavoronkova OI, Stepanova YA, Varava AB, Kovalenko YA, Zharikov YO, Goncharov AB, Olifir AA, Pakhomova AY, Bugaev SA, Zhao AV. Modern principles of hepatocellular carcinoma treatment. Ann hir gepatol 2020;25:15-26. [DOI: 10.16931/1995-5464.2020215-26] [Reference Citation Analysis]
211 Mi N, Cao J, Zhang J, Fu W, Huang C, Gao L, Yue P, Bai B, Lin Y, Meng W, Li X. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis. Oncol Lett 2020;20:1695-708. [PMID: 32724412 DOI: 10.3892/ol.2020.11752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
212 Li Z, Xu J, Cui H, Song J, Chen J, Wei J. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus. Medicine (Baltimore) 2020;99:e20302. [PMID: 32443377 DOI: 10.1097/MD.0000000000020302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
213 Maduekwe UN, Charles A. An invited commentary on "Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis" [Int. J. Surg. (2020) Epub ahead of print]: Does liver anatomy matter? Int J Surg 2020;79:326. [PMID: 32535258 DOI: 10.1016/j.ijsu.2020.06.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Li J, Liu ZY, Yu HB, Xue Q, Qu XS. Effects of oxymatrine on the proliferation of human liver cancer Bel-7404 cells: A protocol of systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20181. [PMID: 32501970 DOI: 10.1097/MD.0000000000020181] [Reference Citation Analysis]
215 Guo X, Wang Y. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Cancer Med 2020;9:5235-46. [PMID: 32462698 DOI: 10.1002/cam4.3046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
216 Ren QP, Luo YL, Xiao FM, Wen TF, Wu MH, Juan-Wan, Xie ZR. Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma. Medicine (Baltimore) 2020;99:e20062. [PMID: 32443312 DOI: 10.1097/MD.0000000000020062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
217 Zhao Y, Ye L, Yu Y. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer. Clin Res Hepatol Gastroenterol 2020;44:865-73. [PMID: 32409283 DOI: 10.1016/j.clinre.2020.03.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
218 Pibiri M, Sulas P, Camboni T, Leoni VP, Simbula G. α-Lipoic acid induces Endoplasmic Reticulum stress-mediated apoptosis in hepatoma cells. Sci Rep 2020;10:7139. [PMID: 32345994 DOI: 10.1038/s41598-020-64004-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
219 Gao Y, Gu J, Wang Y, Fu D, Zhang W, Zheng G, Wang X. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathol Res Pract 2020;216:152981. [PMID: 32527447 DOI: 10.1016/j.prp.2020.152981] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
220 Chen X, Ding L, Kong D, Zhao X, Liao L, Zhang Y, Li F, Liu R. FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis. Open Life Sci 2020;15:259-66. [PMID: 33817214 DOI: 10.1515/biol-2020-0027] [Reference Citation Analysis]
221 Lin H, Zhou W, Huang Y, Ren M, Xu F, Wang H. Systemic hypoxia potentiates anti-tumor effects of metformin in hepatocellular carcinoma in mice. Acta Biochim Biophys Sin (Shanghai) 2020;52:421-9. [PMID: 32250393 DOI: 10.1093/abbs/gmaa010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Huang J, Gu Z, Chen W, Xu Y, Chen M. Knockdown of ubiquitin‐specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c‐Myc expression. The Kaohsiung Journal of Medical Sciences 2020;36:615-21. [DOI: 10.1002/kjm2.12209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
223 Zhang ZM, Tan JX, Wang F, Dao FY, Zhang ZY, Lin H. Early Diagnosis of Hepatocellular Carcinoma Using Machine Learning Method. Front Bioeng Biotechnol 2020;8:254. [PMID: 32292778 DOI: 10.3389/fbioe.2020.00254] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
224 Wang Y, Su GF, Huang ZX, Wang ZG, Zhou PJ, Fan JL, Wang YF. Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC). Expert Opin Ther Targets 2020;24:389-402. [PMID: 32106726 DOI: 10.1080/14728222.2020.1737013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
225 Meng YC, Lou XL, Yang LY, Li D, Hou YQ. Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2020;146:1103-13. [PMID: 32157437 DOI: 10.1007/s00432-020-03174-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
226 Lei Z, Tang X, Si A, Yang P, Wang L, Luo T, Guo G, Zhang Q, Cheng Z. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6. Exp Cell Res 2020;390:111955. [PMID: 32165166 DOI: 10.1016/j.yexcr.2020.111955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
227 Wang L, Zhan Y, Wu Z, Lin M, Jin X, Jiang L, Qiu Y. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells. Biomed Pharmacother 2020;125:110033. [PMID: 32187962 DOI: 10.1016/j.biopha.2020.110033] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
228 Pu J, Wang J, Li W, Lu Y, Wu X, Long X, Luo C, Wei H. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p. J Cell Mol Med 2020. [PMID: 32077624 DOI: 10.1111/jcmm.15010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
229 Chen W, Tang D, Ou M, Dai Y. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes. DNA Cell Biol 2020;39:499-512. [PMID: 32069130 DOI: 10.1089/dna.2019.5099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
230 Bian Y, Guo D. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles. Drug Des Devel Ther 2020;14:647-59. [PMID: 32109990 DOI: 10.2147/DDDT.S238955] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
231 Wei F, Yang L, Jiang D, Pan M, Tang G, Huang M, Zhang J. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis. Cancer Med 2020;9:2480-90. [PMID: 32022476 DOI: 10.1002/cam4.2861] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
232 Liu B, Yang G, Wang X, Liu J, Lu Z, Wang Q, Xu B, Liu Z, Li J. CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR. J Cell Physiol 2020;235:6929-41. [PMID: 32003018 DOI: 10.1002/jcp.29589] [Cited by in Crossref: 19] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
233 Zhang Y, Ying X, Zhao Q, Ma J, Zhang D, He C, Han S. Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ. Dis Markers 2020;2020:2632716. [PMID: 32076459 DOI: 10.1155/2020/2632716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
234 Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst 2020;32:5. [PMID: 32372179 DOI: 10.1186/s43046-020-0016-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
235 Li SQ, Chen Q, Qin HX, Yu YQ, Weng J, Mo QR, Yin XF, Lin Y, Liao WJ. Long Intergenic Nonprotein Coding RNA 0152 Promotes Hepatocellular Carcinoma Progression by Regulating Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway through miR-139/PIK3CA. Am J Pathol 2020;190:1095-107. [PMID: 31954697 DOI: 10.1016/j.ajpath.2019.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
236 Korean Liver Cancer Association., National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019;13:227-99. [PMID: 31060120 DOI: 10.5009/gnl19024] [Cited by in Crossref: 141] [Cited by in F6Publishing: 132] [Article Influence: 70.5] [Reference Citation Analysis]
237 He Y, Dang Q, Li J, Zhang Q, Yu X, Xue M, Guo W. Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set. Aging (Albany NY) 2020;12:965-77. [PMID: 31929113 DOI: 10.18632/aging.102669] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
238 Jiang Z, Wang S, Jin J, Ying S, Chen Z, Zhu D, Xiao B, Hu Y, Qian Y, Cai T, Fu L. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases. J Clin Lab Anal 2020;34:e23200. [PMID: 31916309 DOI: 10.1002/jcla.23200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
239 Ding J, Qin D, Zhang Y, Li Q, Li Y, Li J. SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway. Mol Med Rep 2020;21:1251-7. [PMID: 31922244 DOI: 10.3892/mmr.2020.10908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
240 Liu Q, Zhou C, Zhang B. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis. BMC Gastroenterol 2019;19:230. [PMID: 31888604 DOI: 10.1186/s12876-019-1150-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
241 Sun Y, Zhou Q, Li J, Zhao C, Yu Z, Zhu Q. LncRNA RP11-422N16.3 Inhibits Cell Proliferation and EMT, and Induces Apoptosis in Hepatocellular Carcinoma Cells by Sponging miR-23b-3p. Onco Targets Ther 2019;12:10943-61. [PMID: 31849497 DOI: 10.2147/OTT.S232243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
242 Tong X, Wang Q, Wu D, Bao L, Yin T, Chen H. MEK inhibition by cobimetinib suppresses hepatocellular carcinoma and angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 2020;523:147-52. [PMID: 31836141 DOI: 10.1016/j.bbrc.2019.12.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
243 Lin Y, Liang R, Ye J, Li Q, Liu Z, Gao X, Piao X, Mai R, Zou D, Ge L. A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma. Aging (Albany NY) 2019;11:11157-69. [PMID: 31811111 DOI: 10.18632/aging.102518] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
244 Wu M, Mei F, Liu W, Jiang J. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles. Biomed Pharmacother. 2020;121:109637. [PMID: 31810126 DOI: 10.1016/j.biopha.2019.109637] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
245 Li Y, Ding X, Xiu S, Du G, Liu Y. LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells. Onco Targets Ther 2019;12:9887-97. [PMID: 31819486 DOI: 10.2147/OTT.S228917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
246 Häfner SJ. High hopes and high honours for cancer immunotherapy. Biomed J 2019;42:293-8. [PMID: 31783989 DOI: 10.1016/j.bj.2019.10.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
247 Zhang Z, Wang S, Yang F, Meng Z, Liu Y. LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer. Oncol Rep 2020;43:55-74. [PMID: 31746401 DOI: 10.3892/or.2019.7398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
248 Zhao H, Zhu P, Han T, Ye Q, Xu C, Wu L, Liu F, Yin W, Li Z, Guo Y. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease. J Clin Lab Anal 2020;34:e23075. [PMID: 31659795 DOI: 10.1002/jcla.23075] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
249 Sun JF, Zhang D, Gao CJ, Zhang YW, Dai QS. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN. Med Sci Monit Basic Res 2019;25:218-28. [PMID: 31645540 DOI: 10.12659/MSMBR.918134] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
250 Bai Y, Zheng Z, Du M, Yao H, Liu Y, Suo J. Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance Study. Biomed Res Int 2019;2019:8190475. [PMID: 31781645 DOI: 10.1155/2019/8190475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
251 Avgeris M, Panoutsopoulou K, Papadimitriou MA, Scorilas A. Circulating exosomal miRNAs: clinical significance in human cancers. Expert Rev Mol Diagn 2019;19:979-95. [PMID: 31594418 DOI: 10.1080/14737159.2019.1673732] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
252 Jiang Z, Shen L, Wang S, Wu S, Hu Y, Guo J, Fu L. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma. Cancer Med 2019;8:7278-87. [PMID: 31595711 DOI: 10.1002/cam4.2584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
253 Tong Y, Wang M, Huang H, Zhang J, Huang Y, Chen Y, Pan H. Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line. Exp Ther Med 2019;18:3793-800. [PMID: 31611933 DOI: 10.3892/etm.2019.8027] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
254 Chao Y, Zhou D. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Med Sci Monit 2019;25:6581-6. [PMID: 31475695 DOI: 10.12659/MSM.915100] [Cited by in Crossref: 25] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
255 Huang D, Wei Y, Zhu J, Wang F. Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma. Gene 2019;714:143994. [DOI: 10.1016/j.gene.2019.143994] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
256 Li Z, Mou L, Gao H, Zeng Y, Tang X, Deng X, Pu Z, Ni Y, Zhan Y. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis. Medicine (Baltimore) 2019;98:e16725. [PMID: 31393380 DOI: 10.1097/MD.0000000000016725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
257 Zhao Y, Wang Z, Zhang W, Zhang L. MicroRNAs play an essential role in autophagy regulation in various disease phenotypes. Biofactors. 2019;45:844-856. [PMID: 31418958 DOI: 10.1002/biof.1555] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 8.7] [Reference Citation Analysis]
258 Zhang Z, Wang S, Liu Y, Meng Z, Chen F. Low lncRNA ZNF385D‑AS2 expression and its prognostic significance in liver cancer. Oncol Rep 2019;42:1110-24. [PMID: 31322274 DOI: 10.3892/or.2019.7238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
259 Amili O, Golzarian J, Coletti F. In Vitro Study of Particle Transport in Successively Bifurcating Vessels. Ann Biomed Eng 2019;47:2271-83. [PMID: 31165293 DOI: 10.1007/s10439-019-02293-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
260 Gheena S, Ezhilarasan D. Syringic acid triggers reactive oxygen species–mediated cytotoxicity in HepG2 cells. Hum Exp Toxicol 2019;38:694-702. [DOI: 10.1177/0960327119839173] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
261 Hu B, An HM, Yan X, Zheng JL, Huang XW, Li M. Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells. BMC Complement Altern Med 2019;19:67. [PMID: 30876428 DOI: 10.1186/s12906-019-2477-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
262 Chung MW, Ha SY, Choi JH, Park HJ, Myung DS, Cho SB, Lee WS, Kim JW, Oh HH, Joo YE. Cardiac tamponade after radiofrequency ablation for hepatocellular carcinoma: Case report and literature review. Medicine (Baltimore) 2018;97:e13532. [PMID: 30544457 DOI: 10.1097/MD.0000000000013532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
263 Zhu Q, Yu X, Zhou ZW, Luo M, Zhou C, He ZX, Chen Y, Zhou SF. A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor. J Cancer 2018;9:2061-71. [PMID: 29937924 DOI: 10.7150/jca.20822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
264 Oh SH, Swiderska-Syn M, Jewell ML, Premont RT, Diehl AM. Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes. J Hepatol 2018;69:359-67. [PMID: 29758331 DOI: 10.1016/j.jhep.2018.05.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
265 Son DJ, Hong JY, Kim KH, Jeong YH, Myung DS, Cho SB, Lee WS, Kang YJ, Kim JW, Joo YE. Liver abscess caused by Clostridium haemolyticum infection after transarterial chemoembolization for hepatocellular carcinoma: A case report. Medicine (Baltimore) 2018;97:e0688. [PMID: 29742715 DOI: 10.1097/MD.0000000000010688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
266 Han Y, An Y, Jia G, Wang X, He C, Ding Y, Tang Q. Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma. Nanoscale 2018;10:6511-23. [DOI: 10.1039/c7nr09717d] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
267 Kim KH, Oh HH, Son DJ, Hong JY, Jeong YH, Jung JS, Yu HM, Myung DS, Cho SB, Lee WS, Kim JW, Joo YE. Scapular metastasis of hepatocellular carcinoma presenting as acute bleeding and hematoma: A case report of safe and effective treatment. Medicine (Baltimore) 2017;96:e8736. [PMID: 29145320 DOI: 10.1097/MD.0000000000008736] [Reference Citation Analysis]
268 Liu HN, Wu H, Chen YJ, Tseng YJ, Bilegsaikhan E, Dong L, Shen XZ, Liu TT. Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma. Oncotarget. 2017;8:108810-108824. [PMID: 29312570 DOI: 10.18632/oncotarget.22224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
269 Wang M, Wei C, Shi Z, Zhu J. Study on the diagnosis of small hepatocellular carcinoma caused by hepatitis B cirrhosis via multi-slice spiral CT and MRI. Oncol Lett. 2018;15:503-508. [PMID: 29375718 DOI: 10.3892/ol.2017.7313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]